Discontinued — last reported Q3 '25
DexCom Accrued Liabilities & Other increased by 6.7% to $2.07B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.7%, from $1.69B to $2.07B. Over 5 years (FY 2020 to FY 2025), Accrued Liabilities & Other shows an upward trend with a 32.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase may indicate rising operational costs or deferred payments, while a decrease suggests improved cash management or settlement of obligations.
This represents short-term obligations for expenses incurred but not yet invoiced or paid, alongside miscellaneous curre...
Standard working capital line item found in almost all corporate balance sheets.
accrued_liabilities_and_other_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $482.00M | $598.00M | $573.00M | $603.10M | $688.30M | $764.20M | $901.80M | $965.20M | $1.16B | $1.37B | $1.35B | $1.45B | $1.57B | $1.59B | $1.59B | $1.69B | $1.94B | $1.93B | $1.94B | $2.07B |
| QoQ Change | — | +24.1% | -4.2% | +5.3% | +14.1% | +11.0% | +18.0% | +7.0% | +19.8% | +18.7% | -2.0% | +7.5% | +8.5% | +1.4% | -0.5% | +6.7% | +15.0% | -0.6% | +0.6% | +6.7% |
| YoY Change | — | — | — | — | +42.8% | +27.8% | +57.4% | +60.0% | +68.0% | +79.7% | +49.2% | +49.9% | +35.7% | +16.0% | +17.8% | +16.9% | +23.8% | +21.3% | +22.6% | +22.7% |